A detailed history of Globeflex Capital L P transactions in Mannkind Corp stock. As of the latest transaction made, Globeflex Capital L P holds 91,257 shares of MNKD stock, worth $640,624. This represents 0.06% of its overall portfolio holdings.

Number of Shares
91,257
Previous 91,257 -0.0%
Holding current value
$640,624
Previous $476,000 20.38%
% of portfolio
0.06%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.05 - $5.43 $28,305 - $37,950
-6,989 Reduced 7.11%
91,257 $476,000
Q1 2024

May 14, 2024

SELL
$3.25 - $5.27 $27,163 - $44,046
-8,358 Reduced 7.84%
98,246 $445,000
Q4 2023

Feb 13, 2024

BUY
$3.34 - $4.29 $110,233 - $141,587
33,004 Added 44.84%
106,604 $388,000
Q1 2023

May 12, 2023

SELL
$3.95 - $5.63 $148,654 - $211,879
-37,634 Reduced 33.83%
73,600 $301,000
Q4 2022

Feb 10, 2023

BUY
$3.02 - $5.37 $335,926 - $597,326
111,234 New
111,234 $586,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.